FOXO4-DRI Peptide research-grade
FOXO4-DRI Peptide

FOXO4-DRI Peptide

$217.00

Research-grade FOXO4-DRI Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

FOXO4-DRI Peptide research-grade

Overview

FOXO4-DRI Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for FOXO4-DRI Peptide

Work involving FOXO4-DRI Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of FOXO4-DRI Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source FOXO4-DRI Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with FOXO4-DRI Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using FOXO4-DRI Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of FOXO4-DRI Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 6 PubMed records. Displaying 10 per page.

  1. Bourgeois B et al. (2025). The disordered p53 transactivation domain is the target of FOXO4 and the senolytic… [PMID: 40593617]

    Laboratory literature summary: The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Hu Z et al. (2025). FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway [PMID: 41625068]

    Laboratory literature summary: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Huang Y et al. (2021). Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded… [PMID: 33996787]

    Laboratory literature summary: Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded research subjects Chondrocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Kong YX et al. (2025). FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion… [PMID: 39994346]

    Laboratory literature summary: FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Li Y et al. (2024). FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated… [PMID: 39025385]

    Laboratory literature summary: FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Zhang C et al. (2020). FOXO4-DRI alleviates age-related androgen-pathway markers secretion insufficiency by… [PMID: 31959736]

    Laboratory literature summary: FOXO4-DRI alleviates age-related androgen-pathway markers secretion insufficiency by targeting senescent Leydig cells in aged mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

2 mg, 5 mg, 10 mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is FOXO4-DRI peptide?

FOXO4-DRI is a synthetic peptide designed to interact with FOXO4-related pathways. It is commonly studied in research laboratories for its role in cellular signaling and senescence-related mechanisms.

What is FOXO4-DRI used for in research?

FOXO4-DRI is used in research laboratories to investigate cellular senescence, protein interactions, and regulatory biological pathways. It is not approved for human use.

Is FOXO4-DRI Peptide approved or intended for human use?

No. FOXO4-DRI is strictly intended for research purposes only and is not approved by the FDA for human use.

Is FOXO4-DRI Peptide FDA-approved for medical or clinical use?

No. FOXO4-DRI is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is FOXO4-DRI supplied?

FOXO4-DRI is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories

How should FOXO4-DRI be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for FOXO4-DRI?

FOXO4-DRI is available in multiple vial sizes.

Is FOXO4-DRI Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is FOXO4-DRI shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify FOXO4-DRI purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/